Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications [1]. Group 1: Legal Action Details - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, may be eligible for compensation without upfront costs through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - The lawsuit alleges that Marex made materially false statements and failed to disclose critical information regarding its financial practices, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Points - Rosen Law Firm is reminding investors who purchased securities of Marex Group plc between May 16, 2024, and August 5, 2025, about the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Case Details - The lawsuit alleges that during the Class Period, Marex made materially false and misleading statements and failed to disclose critical information, including: 1. Marex sold over-the-counter financial instruments to itself 2. There were inconsistencies in financial statements between subsidiaries and related parties 3. Marex's financial statements could not be relied upon 4. Positive statements about Marex's business were materially misleading [4] Legal Representation - Investors are encouraged to select qualified counsel with a successful track record in securities class actions, as many firms may not have the necessary experience or resources [3] - Rosen Law Firm has achieved significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [3]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by December 8, 2025 [3][6]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false and misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [6]. - A report from NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions, including a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [7]. - Following the release of the report, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 on heavy trading volume [9]. Group 2: Legal Actions and Investor Options - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995, indicating its capability in handling such cases [5]. - Any member of the putative class can move the court to serve as lead plaintiff or choose to remain an absent class member, with no impact on their ability to share in any recovery [10].

Core Points - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the Class Period from May 16, 2024, to August 5, 2025, to secure legal counsel before the December 8, 2025, deadline for lead plaintiff applications [1][5]. Group 1: Legal Action Details - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in securing significant settlements for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and recovering over $438 million for investors in 2019 [4].

Core Points - Rosen Law Firm is reminding investors who purchased Marex Group plc securities between May 16, 2024, and August 5, 2025, of the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Marex securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by December 8, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that during the Class Period, Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - It is claimed that Marex's financial statements could not be relied upon, and positive statements about the company's business were materially misleading [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit set for December 8, 2025 [3][8]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false and misleading statements, failing to disclose significant issues such as selling over-the-counter financial instruments to itself and inconsistencies in financial statements [6]. - A report by NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions, including a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [7]. - Following the release of the report, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 [9]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [2]. - The role of lead plaintiff in the class action lawsuit is designated for the investor with the largest financial interest, who will oversee the litigation on behalf of the class [10]. - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding Marex's conduct [11].

Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications [1][2]. Group 1: Class Action Details - The class period for the Marex Group plc securities class action is from May 16, 2024, to August 5, 2025 [1]. - Investors who purchased Marex securities during this period may be eligible for compensation without any upfront costs through a contingency fee arrangement [2]. - To participate in the class action, investors must apply by December 8, 2025, to serve as lead plaintiff, representing other class members [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in this area [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in terms of settlements secured for investors [4]. Group 3: Allegations Against Marex - The lawsuit alleges that during the class period, Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - As a result of these actions, Marex's financial statements were deemed unreliable, leading to misleading positive statements about the company's business and operations [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Primo Brands Corporation due to alleged violations of federal securities laws related to misleading statements about the merger with BlueTriton Brands and its integration process [2][4]. Group 1: Allegations and Impact - The complaint alleges that Primo Brands and its executives made false and misleading statements regarding the merger, leading investors to believe it would enhance growth and operational efficiencies [4]. - Issues began to surface on August 7, 2025, when Primo Brands reported Q2 2025 earnings, revealing disruptions in product supply and service due to the merger, resulting in a stock price drop of $2.41 or approximately 9% [4][6]. - On November 6, 2025, the company significantly reduced its full-year 2025 net sales and adjusted EBITDA guidance, and announced the replacement of CEO Rietbroek, with new CEO Eric Foss admitting that integration efforts were rushed, causing various operational issues [5]. Group 2: Stock Performance - Following the November 6 disclosure, Primo Brands' stock fell by $8.20 or 36% over two trading sessions, dropping from $22.66 on November 5, 2025, to $14.46 on November 7, 2025 [6]. Group 3: Legal Proceedings - Investors who purchased securities during the specified class periods are encouraged to contact Faruqi & Faruqi to discuss their legal rights, with a deadline of January 12, 2026, to seek the role of lead plaintiff in the class action [2][7]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding the company's conduct [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. for allegedly misleading investors regarding the company's competitive positioning and financial performance during the specified class period [1][3]. Group 1: Allegations Against Avantor - The complaint alleges that Avantor and its executives violated federal securities laws by making false and misleading statements about the company's competitive position and the impact of increased competition [3]. - Defendants are accused of downplaying the effects of competition, with the CEO previously assuring investors of the company's strong competitive standing during earnings calls [4]. Group 2: Financial Performance and Stock Impact - Investors became aware of the negative impact of competition on Avantor's business when the company reported disappointing Q1 2025 results, leading to a stock price decline of over 16.5% [5][6]. - Following further disappointing financial results in Q2 2025, including a projected organic revenue growth of -2% to 0%, the stock price fell by more than 15% [5][6]. - In Q3 2025, Avantor reported a net loss of $712 million, primarily due to a non-cash goodwill impairment charge of $785 million, which was attributed to competitive pressures, resulting in a stock price drop of over 23% [7][8].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status by December 8, 2025 [1][3]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false or misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [3]. - Specific allegations include a multi-year accounting scheme involving off-balance-sheet entities, fictitious transactions, and misleading disclosures to hide losses and inflate profits, with examples such as a $17 million fabricated receivable and nearly $1 billion in concealed derivatives exposure [4]. - Following the release of a damaging report, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 on heavy trading volume [5]. Group 2: Legal Proceedings and Investor Actions - The lead plaintiff in the class action will be the investor with the largest financial interest who is adequate and typical of class members, and any member of the class may move to serve as lead plaintiff [6]. - Faruqi & Faruqi encourages individuals with information regarding Marex's conduct, including whistleblowers and former employees, to come forward [6].